These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of gadolinium-DTPA and polylysine-gadolinium-DTPA--enhanced magnetic resonance imaging of hepatocarcinoma in the rat. Grandin C; Van Beers BE; Demeure R; Goudemant JF; Mottet I; Pringot J Invest Radiol; 1995 Oct; 30(10):572-81. PubMed ID: 8557496 [TBL] [Abstract][Full Text] [Related]
5. Gd-DTPA adrenal gland enhancement at 1.5 T. Small WC; Bernardino ME Magn Reson Imaging; 1991; 9(3):309-12. PubMed ID: 1881248 [TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced MR imaging of the upper abdomen: enhancement properties of gadobutrol, gadolinium-DTPA-polylysine, and gadolinium-DTPA-cascade-polymer. Adam G; Neuerburg J; Spüntrup E; Mühler A; Scherer K; Günther RW Magn Reson Med; 1994 Nov; 32(5):622-8. PubMed ID: 7808263 [TBL] [Abstract][Full Text] [Related]
8. NMR imaging study of the pharmacodynamics of polylysine-gadolinium-DTPA in the rabbit and the rat. Van Hecke P; Marchal G; Bosmans H; Johannik K; Jiang Y; Vogler H; Van Ongeval C; Baert AL; Speck U Magn Reson Imaging; 1991; 9(3):313-21. PubMed ID: 1881249 [TBL] [Abstract][Full Text] [Related]
10. Glioblastoma multiforme: MR imaging at 1.5 and 9.4 T after injection of polylysine-DTPA-Gd in rats. Kornguth S; Anderson M; Turski P; Sorenson J; Robins HI; Cohen J; Rappe A; Markley J AJNR Am J Neuroradiol; 1990; 11(2):313-8. PubMed ID: 2156411 [TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced MR imaging of the kidneys and adrenal glands. Huch Böni RA; Debatin JF; Krestin GP Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):101-31. PubMed ID: 8673709 [TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging detection of an experimental pulmonary perfusion deficit using a macromolecular contrast agent. Polylysine-gadolinium-DTPA40. Berthezène Y; Vexler V; Price DC; Wisner-Dupon J; Moseley ME; Aicher KP; Brasch RC Invest Radiol; 1992 May; 27(5):346-51. PubMed ID: 1582816 [TBL] [Abstract][Full Text] [Related]
14. A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. Bogdanov AA; Weissleder R; Frank HW; Bogdanova AV; Nossif N; Schaffer BK; Tsai E; Papisov MI; Brady TJ Radiology; 1993 Jun; 187(3):701-6. PubMed ID: 8497616 [TBL] [Abstract][Full Text] [Related]
15. Characterization of a gadolinium-labeled cholesterol derivative as an organ-specific contrast agent for adrenal MR imaging. Mühler A; Platzek J; Radüchel B; Frenzel T; Weinmann HJ J Magn Reson Imaging; 1995; 5(1):7-10. PubMed ID: 7696812 [TBL] [Abstract][Full Text] [Related]
16. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging. Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380 [TBL] [Abstract][Full Text] [Related]
18. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats. Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739 [TBL] [Abstract][Full Text] [Related]
19. Functional hepatobiliary imaging with gadolinium-EOB-DTPA. A comparison of magnetic resonance imaging and 153gadolinium-EOB-DTPA scintigraphy in rats. Schmitz SA; Mühler A; Wagner S; Wolf KJ Invest Radiol; 1996 Mar; 31(3):154-60. PubMed ID: 8675423 [TBL] [Abstract][Full Text] [Related]
20. Improved method for in vivo magnetic resonance contrast media research. Schmiedl UP; Maravilla KR; Nelson JA Invest Radiol; 1991 Jan; 26(1):65-70. PubMed ID: 2022455 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]